Loading…
Live market data via Yahoo Finance · updated 8/4/2026
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. It operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
The DMS segment manufactures scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the BASi product line.
The company was formerly known as Bioanalytical Systems, Inc. and changed its name to Inotiv, Inc. in March 2021. Inotiv was incorporated in 1974 and is headquartered in West Lafayette, Indiana.
On June 3, 2026, Inotiv, Inc. along with its affiliates filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
NOTV currently trades at $0.0799 per share with a market capitalization of $2.79M. It ranks 5434 by market cap. The forecast path through 2026 to 2050 shows fluctuating downside and upside, beginning with a neutral 2026 and moving into bullish territory by 2030 and beyond, with a wide range of potential outcomes.
In 2026 the min, avg, and max are $0.0081, $0.0799, and $0.0854 respectively, with a neutral outlook. The 2030 forecast shows a bullish tilt with an average of $0.1058 and a max of $0.1837, yielding a 32.5% ROI. The 2040 and 2050 forecasts remain bullish, with averages of $0.1108 and $0.2282 and ROIs of 38.6% and 185.6%, respectively.
The path includes years with negative or smaller returns, such as 2027 with a -15.3% ROI, illustrating the potential for volatility.
A major floor 89.9% below — a decisive break under it would weaken the trend.
The nearest floor, 86.1% below — buyers have tended to step in here.
Resistance now sits 86.1% below — it may act as fresh support.
A major ceiling 463.2% above — clearing it would confirm fresh momentum.
Key NOTV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of NOTV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.0111 | Buy | $0.0112 | Buy |
| MA 10 | $0.0113 | Buy | $0.0135 | Buy |
| MA 20 | $0.0132 | Buy | $0.0348 | Buy |
| MA 50 | $0.1475 | Sell | $0.119 | Sell |
| MA 100 | $0.226 | Sell | $0.259 | Sell |
| MA 200 | $0.5544 | Sell | $0.622 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 27.41 | Buy |
| Stoch RSI (14) | 84.29 | Sell |
| CCI (20) | -39.87 | Neutral |
| Williams %R (14) | -45.95 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 37.04 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 54.05 | Neutral |
| TRIX (15) | -6.38 | Sell |
| Awesome (5,34) | -0.07 | Sell |
| Ultimate (7,14,28) | 74.37 | Sell |
| Momentum (10) | 0.00 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 0.01 | Buy |
| ADX (14) | 40.36 | Sell |
| ATR (14) | 0.01 | Info |
The 30-day technical picture is neutral. RSI14 is 30, indicating subdued momentum. The asset trades above a short term moving baseline: SMA50 is $0.1872 and SMA200 is $0.6024.
Support is placed at $0.0081 and resistance at $0.3058, framing a wide range around the current level. The 30-day price range spans from $0.0283 to $0.2258, underscoring the stock's constrained near term activity amid high volatility, reflected in an annualized volatility of 300%.
See what a past investment in NOTVwould be worth at today's price.
$1,000 invested in NOTV on Jul 28, 2025 (≈ 465.116258 NOTV) would be worth
$37.16
-$962.84 (-96.3%) today · 0.04× · US Dollar
Based on a NOTV entry price of $2.15 vs. today's $0.0799.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.0111 | $7,198.2 | +619.8% |
| 1 month ago | $0.012 | $6,658.33 | +565.8% |
| 3 months ago | $0.29 | $275.52 | -72.4% |
| 6 months ago | $0.52 | $153.65 | -84.6% |
| 1 year ago | $2.15 | $37.16 | -96.3% |
| All time (5.0y) ago | $25.2 | $3.17 | -99.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
The multi year forecast shows notable upside by 2030 and beyond. In 2030 the average price is forecast at $0.1058 with a max of $0.1837 and a min of $0.0654, delivering a 32.5% ROI and a bullish sentiment. In 2040 the average price is forecast at $0.1108 with a max of $0.2432, a 38.6% ROI, and bullish sentiment.
By 2050 the average price is forecast at $0.2282 with a max of $0.5248, a 185.6% ROI, and bullish sentiment.
The forecast also shows a range of outcomes in intermediate years, including 2027 with a -15.3% ROI and 2034 with a -4.1% ROI, reflecting continued volatility. Overall, the long horizon points to meaningful upside potential, but drift and pullbacks are possible along the way. Given the referenced volatility, these are estimates rather than guarantees and should be considered within a broader risk tolerance.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.1058 with a max of $0.1837 and a min of $0.0654, delivering a 32.5% ROI. The sentiment is bullish, but these are estimates, not guarantees.
Forecasts show mixed results across years. 2026 yields an average of $0.0799 with 0% ROI, 2027 shows a bearish -15.3% ROI, while 2030, 2031, 2040, and 2050 show positive ROIs of 32.5%, 24.7%, 38.6%, and 185.6% respectively. These are estimates and not guaranteed.
Yes. The max forecast by 2050 is $0.5248, which exceeds $0.30. For reference, 2050 max is $0.5248 and 2040 max is $0.2432.
The current price is $0.0799 and the market capitalization is $2.79M.
Yes. On June 3, 2026, Inotiv, Inc. along with its affiliates filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.
Inotiv Inc Community Discussion
0Share your Inotiv Inc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.